Literature DB >> 7222652

Hypercalcemia, pneumothorax and pneumoperitoneum in a patient with pulmonary mycobacteriosis and esophageal carcinoma.

A Baydur, U Slager, V M Anderson.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 7222652      PMCID: PMC1272202     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  25 in total

1.  Unusual manifestations of carcinoma of the esophagus.

Authors:  G T WOHL; B H PASTOR; S L KARR
Journal:  N Engl J Med       Date:  1955-04-28       Impact factor: 91.245

2.  Spontaneous pneumothorax and pulmonary malignant disease--a syndrome sometimes associated with cavitating tumours. Report of nine new cases, four with metastases and five with primary bronchial tumours.

Authors:  F W Wright
Journal:  Clin Radiol       Date:  1976-04       Impact factor: 2.350

3.  Clearance of inhaled particles from alveoli by normal interstitial drainage pathways.

Authors:  A D Tucker; J H Wyatt; D Undery
Journal:  J Appl Physiol       Date:  1973-11       Impact factor: 3.531

4.  The chloride-phosphate ratio in hypercalcemia.

Authors:  F J Palmer; J C Nelson; H Bacchus
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

5.  Spontaneous pneumothorax and pneumomediastinum as complications of sarcoma.

Authors:  J F Laucius; H S Brodovsky; C D Howe
Journal:  J Thorac Cardiovasc Surg       Date:  1972-09       Impact factor: 5.209

6.  Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease.

Authors:  R C Benson; B L Riggs; B M Pickard; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

7.  Biologic activity of ectopic parathyroid hormone.

Authors:  S A Metz
Journal:  N Engl J Med       Date:  1977-01-13       Impact factor: 91.245

8.  Pneumoperitoneum. A complication of mechanical ventilation.

Authors:  J T Stringfield; J P Graham; C M Watts; R R Bentz; J G Weg
Journal:  JAMA       Date:  1976-02-16       Impact factor: 56.272

9.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

10.  Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer.

Authors:  B L Riggs; C D Arnaud; J C Reynolds; L H Smith
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.